Last edition
News about "Pfizer to acquire Trillium Therapeutics"
Pfizer to acquire Trillium Therapeutics
Pfizer and Trillium Therapeutics yesterday announced that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium, a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer. Under the terms of the agreement
Pfizer To Acquire Trillium Therapeutics | 24/08/2021 | By Darshana | 334
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members